CBRE vs SUNPHARMA.NS — which is stronger right now?
Same dated snapshot (2026-09-01): CBRE quality 100/100 vs SUNPHARMA.NS —/100; engine LONG vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| CBRE (CBRE) | SUNPHARMA.NS (Sun Pharmaceutical) | |
| Market / sector | us · Real Estate | in · Pharma |
| Price | $147.22 | ₹1,913 |
| Quality score | 100/100 | —/100 |
| Engine signal | LONG · 39 bars · uPnL +4.0% | LONG · 235 bars · uPnL +16.0% |
| Total return | +12.9% | +8.4% |
Thesis-break template (Real Estate)
consecutive transfer declines; funding costs outrunning launch prices; aging completed inventory; mortgage tightening
Cite this page
Balance Labs Research Desk (2026-09-01). "CBRE vs SUNPHARMA.NS — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/cbre-vs-sunpharma.ns · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice